Page last updated: 2024-12-07

ksg 504

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

KSG 504: has superior selectivity and affinity to CCK-A receptors; derived from proglumide [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID132011
MeSH IDM0226329

Synonyms (10)

Synonym
l-arginine, mono((r)-5-((3-methoxypropyl)pentylamino)-4-((2-naphthalenylsulfonyl)methyl)-5-oxopentanoate)
137005-17-5
ksg-504
ksg 504
4-n-(3-methoxypropyl)-n-pentylcarbamoyl-5-(2-naphthylsulfonyl)pentanoic acid
AKOS030531694
DTXSID70929658
arginine--5-[(3-methoxypropyl)(pentyl)amino]-4-[(naphthalene-2-sulfonyl)methyl]-5-oxopentanoic acid (1/1)
(2s)-2-amino-5-(diaminomethylideneamino)pentanoic acid;(4r)-5-[3-methoxypropyl(pentyl)amino]-4-(naphthalen-2-ylsulfonylmethyl)-5-oxopentanoic acid
l-arginine, mono[(4r)-5-[(3-methoxypropyl)pentylamino]-4-[(2-naphthalenylsulfonyl)methyl]-5-oxopentanoate] (9ci)

Research Excerpts

[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (12)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's12 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other13 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]